Subscribe
shutterstock_1086968018_jarretera-2
Jarretera / Shutterstock.com
3 November 2020AmericasRory O'Neill

US agencies to work together against COVID-19 fakes

US federal agencies are to step up their cooperation on stemming the flow of counterfeit drugs, medical devices, and dietary supplements into the country through the international mail system.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
US customs raids find thousands of fake COVID-19 test kits
5 May 2020   US customs authorities have seized tens of thousands of counterfeit and unapproved COVID-19 test kits, largely sent through the postal system, since the beginning of the pandemic.
Americas
US customs seize ‘astonishing’ amount of counterfeit COVID-19 masks
8 October 2020   US Customs and Border Protection officers have seized hundreds of thousands of counterfeit facemasks and unapproved COVID-19 related products worth more than $2.5m during the six weeks leading up to October 1.
Americas
ICE targets COVID-19 vaccine fraud after seizing proceeds worth $26m
2 December 2020   The US Immigration and Customs Enforcement has unveiled the next stage of its operation to combat a wave of fraudulent vaccines and treatments, after seizing more than $26 million in illicit proceeds from COVID-19 related products over the past six months.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

More on this story

Americas
ICE targets COVID-19 vaccine fraud after seizing proceeds worth $26m
2 December 2020   The US Immigration and Customs Enforcement has unveiled the next stage of its operation to combat a wave of fraudulent vaccines and treatments, after seizing more than $26 million in illicit proceeds from COVID-19 related products over the past six months.
Americas
US customs raids find thousands of fake COVID-19 test kits
5 May 2020   US customs authorities have seized tens of thousands of counterfeit and unapproved COVID-19 test kits, largely sent through the postal system, since the beginning of the pandemic.
Americas
US customs seize ‘astonishing’ amount of counterfeit COVID-19 masks
8 October 2020   US Customs and Border Protection officers have seized hundreds of thousands of counterfeit facemasks and unapproved COVID-19 related products worth more than $2.5m during the six weeks leading up to October 1.

More on this story

Americas
ICE targets COVID-19 vaccine fraud after seizing proceeds worth $26m
2 December 2020   The US Immigration and Customs Enforcement has unveiled the next stage of its operation to combat a wave of fraudulent vaccines and treatments, after seizing more than $26 million in illicit proceeds from COVID-19 related products over the past six months.
Americas
US customs raids find thousands of fake COVID-19 test kits
5 May 2020   US customs authorities have seized tens of thousands of counterfeit and unapproved COVID-19 test kits, largely sent through the postal system, since the beginning of the pandemic.
Americas
US customs seize ‘astonishing’ amount of counterfeit COVID-19 masks
8 October 2020   US Customs and Border Protection officers have seized hundreds of thousands of counterfeit facemasks and unapproved COVID-19 related products worth more than $2.5m during the six weeks leading up to October 1.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York